Reference115 articles.
1. Swartz SL, Dluhy RG. Corticosteroids: clinical pharmacology and therapeutic use. Drugs 1978; 16:238–255.
2. Kozower M, Veatch L, Kaplan MM. Decreased clearance of prednisolone, a factor in the develpment of corticoisteroid side effects. J Clin Endocrinol Metab 1974; 38:407–412.
3. Homik JE, Cranney A, Shea B, et al. A metaanalysis on the use of bisphosphonates in corticosteroid induced osteoporosis. J Rheumatol 1999; 26(5):1148–1157.
4. Adachi J, Saag KG, Delmas PD, et al. Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids. Arthritis Rheum 2001; 44(1):202–211.
5. Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. N Engl J Med 1998; 339(5).292–299.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Steroid-Induced Osteoporosis;The Bone and Mineral Manual;2005